欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0218/001
药品名称Domosedan Gel 7.6 mg/ml oromucosal gel
活性成分
    • detomidine hydrochloride 7.6 mg
剂型Oromucosal gel
上市许可持有人Orion Corporation Orionintie 1 FI-02200 Espoo Finland
参考成员国 - 产品名称Ireland (IE)
Domosedan Gel 7.6mg/ml oromucosal gel
互认成员国 - 产品名称
    • Germany (DE)
      DOMOSEDAN GEL
    • Denmark (DK)
      Domosedan Gel.
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • France (FR)
      DOMOSEDAN GEL 7,6 MG/ML
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Domosedan gel 7.6 mg/ml oromucosal gel
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      Domosedan Gel
    • Hungary (HU)
    • Bulgaria (BG)
      Domosedan Gel
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2008/10/01
最近更新日期2023/06/09
药物ATC编码
    • QN05CM90 detomidine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase